{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:53:27Z","timestamp":1780350807852,"version":"3.54.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ARS01_01226"],"award-info":[{"award-number":["ARS01_01226"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.neuropharm.2025.110302","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T19:07:54Z","timestamp":1736795274000},"page":"110302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Restorative properties of chronic lurasidone treatment on emotional dysfunction in rats exposed to chronic unavoidable stress: A role for medial prefrontal cortex - nucleus accumbens network"],"prefix":"10.1016","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9845-885X","authenticated-orcid":false,"given":"Eleonora","family":"Corridori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9140-9158","authenticated-orcid":false,"given":"Sara","family":"Salviati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Begni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Marchesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-7668","authenticated-orcid":false,"given":"Carla","family":"Gambarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-5060","authenticated-orcid":false,"given":"Marco Andrea","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Scheggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib1","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/s41598-023-29609-6","article-title":"Patterns of Arc mRNA expression in the rat brain following dual recall of fear- and reward-based socially acquired information","volume":"13","author":"Agee","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110302_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110885","article-title":"Transcriptomic analyses of rats exposed to chronic mild stress: modulation by chronic treatment with the antipsychotic drug lurasidone","volume":"129","author":"Begni","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110302_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.euroneuro.2022.06.005","article-title":"Exposure to chronic stress impairs the ability to cope with an acute challenge: modulation by lurasidone treatment","volume":"61","author":"Begni","year":"2022","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110302_bib82","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbi.2024.10.001","article-title":"Chronic treatment with the antipsychotic lurasidone modulates the neuroinflammatory changes associated with the vulnerability to chronic mild stress exposure in female rats","volume":"123","author":"Begni","year":"2025","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110302_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"7474","key":"10.1016\/j.neuropharm.2025.110302_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature12743","article-title":"The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition","volume":"503","author":"Bloodgood","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110302_bib6","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/npp.2017.153","article-title":"Accumbens mechanisms for cued sucrose seeking","volume":"42","author":"Bobadilla","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110302_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2019.01.002","article-title":"Pharmacological interventions targeting anhedonia in patients with major depressive disorder: a systematic review","volume":"92","author":"Cao","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110302_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","article-title":"Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype","volume":"70","author":"Cates","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110302_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105159","article-title":"The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: insight from meta-analyses","volume":"149","author":"Cavaleri","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110302_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neuron.2008.05.024","article-title":"Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA","volume":"59","author":"Chen","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110302_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1742-1241.2010.02587.x","article-title":"Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic","volume":"65","author":"Citrome","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2025.110302_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cobeha.2018.01.024","article-title":"Anhedonia in depression: biological mechanisms and computational models","volume":"22","author":"Cooper","year":"2018","journal-title":"Curr Opin Behav Sci"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110302_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S1092852915000917","article-title":"Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study","volume":"21","author":"Correll","year":"2016","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00213-023-06343-5","article-title":"Early effects of lurasidone treatment in a chronic mild stress model in male rats","volume":"240","author":"Creutzberg","year":"2023","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110302_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaac.2017.10.006","article-title":"Efficacy and safety of surasidone in children and adolescents with Bipolar I Depression: a double-blind, placebo-controlled study","volume":"56","author":"DelBello","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","article-title":"The neurobiology of anhedonia and other reward-related deficits","volume":"35","author":"Der-Avakian","year":"2012","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/da.23072","article-title":"Association between anhedonia and suicidal events in patients with mood disorders: a 3-year prospective study","volume":"38","author":"Ducasse","year":"2021","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib19","doi-asserted-by":"crossref","first-page":"R876","DOI":"10.1152\/ajpregu.00655.2010","article-title":"Sucrose self-administration and CNS activation in the rat","volume":"300","author":"Figlewicz","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.euroneuro.2014.11.010","article-title":"The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder","volume":"25","author":"Fountoulakis","year":"2015","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110302_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S1461145711000150","article-title":"Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress","volume":"15","author":"Fumagalli","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110302_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/j.celrep.2019.10.116","article-title":"Phosphorylation of Npas4 by MAPK regulates reward-related gene expression and behaviors","volume":"29","author":"Funahashi","year":"2019","journal-title":"Cell Rep."},{"issue":"28","key":"10.1016\/j.neuropharm.2025.110302_bib23","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1523\/JNEUROSCI.3952-07.2008","article-title":"Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase","volume":"28","author":"Gerfen","year":"2008","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110302_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jamapsychiatry.2020.2139","article-title":"Reward-processing behavior in depressed participants relative to healthy volunteers: a systematic review and meta-analysis","volume":"77","author":"Halahakoon","year":"2020","journal-title":"JAMA Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110302_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neubiorev.2009.11.019","article-title":"Neural mechanisms of acquired phasic dopamine responses in learning","volume":"34","author":"Hazy","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3483","key":"10.1016\/j.neuropharm.2025.110302_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","article-title":"Progressive ratio as a measure of reward strength","volume":"134","author":"Hodos","year":"1961","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110302_bib27","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00213-018-4972-y","article-title":"5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA","volume":"235","author":"Huang","year":"2018","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110302_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jnc.12512","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism","volume":"128","author":"Huang","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110302_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75631","article-title":"NPAS4 in the medial prefrontal cortex mediates chronic social defeat stress-induced anhedonia-like behavior and reductions in excitatory synapses","volume":"12","author":"Hughes","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-5380-3-12","article-title":"Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis","volume":"3","author":"Huys","year":"2013","journal-title":"Biol. Mood Anxiety Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110302_bib32","first-page":"24","article-title":"Lurasidone: a clinical overview","volume":"72","author":"Kane","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"7483","key":"10.1016\/j.neuropharm.2025.110302_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature12983","article-title":"Interneuron cell types are fit to function","volume":"505","author":"Kepecs","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib34","first-page":"1","article-title":"Synapse development organized by neuronal activity-regulated immediate-early genes","volume":"50","author":"Kim","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110302_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2011.08.007","article-title":"Arc in synaptic plasticity: from gene to behavior","volume":"34","author":"Korb","year":"2011","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3758\/s13415-022-01001-3","article-title":"Effects of dopamine modulation on chronic stress-induced deficits in reward learning","volume":"22","author":"Lamontagne","year":"2022","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"45","key":"10.1016\/j.neuropharm.2025.110302_bib37","doi-asserted-by":"crossref","first-page":"16447","DOI":"10.1523\/JNEUROSCI.3070-11.2011","article-title":"Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats","volume":"31","author":"Larson","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110302_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/nyas.12965","article-title":"The development of lurasidone for bipolar depression","volume":"1358","author":"Loebel","year":"2015","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00013.2009","article-title":"The function of activity-regulated genes in the nervous system","volume":"89","author":"Loebrich","year":"2009","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110302_bib40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.euroneuro.2013.12.010","article-title":"Delayed BDNF alterations in the prefrontal cortex of rats exposed to prenatal stress: preventive effect of lurasidone treatment during adolescence","volume":"24","author":"Luoni","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu061","article-title":"Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex","volume":"18","author":"Luoni","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110302_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2013.12.008","article-title":"Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment","volume":"50","author":"Luoni","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1037\/rev0000033","article-title":"Learned helplessness at fifty: insights from neuroscience","volume":"123","author":"Maier","year":"2016","journal-title":"Psychol. Rev."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110302_bib44","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S1461145712001654","article-title":"Anti-anhedonic activity of long-term lithium treatment in rats exposed to repeated unavoidable stress","volume":"16","author":"Marchese","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110302_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"Marcus","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110302_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2009.11.001","article-title":"Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment","volume":"67","author":"McCabe","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/ijms21041375","article-title":"The relationships between stress, mental disorders, and epigenetic regulation of BDNF","volume":"21","author":"Miao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110302_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85011","article-title":"Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation","volume":"12","author":"Mohebi","year":"2023","journal-title":"Elife"},{"issue":"7759","key":"10.1016\/j.neuropharm.2025.110302_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41586-019-1235-y","article-title":"Dissociable dopamine dynamics for learning and motivation","volume":"570","author":"Mohebi","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110302_bib50","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/jnc.15297","article-title":"Circuit selectivity in drug versus natural reward seeking behaviors","volume":"157","author":"Nall","year":"2021","journal-title":"J. Neurochem."},{"issue":"Suppl. E1","key":"10.1016\/j.neuropharm.2025.110302_bib51","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110302_bib52","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110302_bib53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.euroneuro.2017.08.427","article-title":"Striatal dopamine D2\/3 receptor-mediated neurotransmission in major depression: implications for anhedonia, anxiety and treatment response","volume":"27","author":"Peci\u00f1a","year":"2017","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110302_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2025.110302_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","article-title":"Depression, stress, and anhedonia: toward a synthesis and integrated model","volume":"10","author":"Pizzagalli","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110302_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neubiorev.2016.03.004","article-title":"Assessing anhedonia in depression: potentials and pitfalls","volume":"65","author":"Rizvi","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110302_bib58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ijnp\/pyy046","article-title":"Chronic stress exposure reduces parvalbumin expression in the rat hippocampus through an imbalance of redox mechanisms: restorative effect of the antipsychotic lurasidone","volume":"21","author":"Rossetti","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"76","author":"Salamone","year":"2012","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","article-title":"Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits","volume":"191","author":"Salamone","year":"2007","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib61","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1038\/s41467-024-53690-8","article-title":"Temporal dynamics of nucleus accumbens neurons in male mice during reward seeking","volume":"15","author":"Schall","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jnc.14558","article-title":"DARPP-32 in the orchestration of responses to positive natural stimuli","volume":"147","author":"Scheggi","year":"2018","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110302_bib63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/ijnp\/pyy083","article-title":"Making sense of rodent models of anhedonia","volume":"21","author":"Scheggi","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2025.110302_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuropharm.2016.07.024","article-title":"PPAR\u03b1 modulation of mesolimbic dopamine transmission rescues depression-related behaviors","volume":"110","author":"Scheggi","year":"2016","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110302_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00849","article-title":"Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms","volume":"4","author":"Scheggi","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2025.110302_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2015.02.006","article-title":"Impramine, fluoxetine and clozapine differently affected reactivity to positive and negative stimuli in a model of motivational anhedonia in rats","volume":"291","author":"Scheggi","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110302_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jad.2017.10.032","article-title":"Aripiprazole relieves motivational anhedonia in rats","volume":"227","author":"Scheggi","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110302_bib68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neubiorev.2016.05.021","article-title":"Reappraising striatal D1- and D2-neurons in reward and aversion","volume":"68","author":"Soares-Cunha","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110302_bib69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cell.2014.03.058","article-title":"Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs","volume":"157","author":"Spiegel","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110302_bib70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tins.2016.02.003","article-title":"Npas4: linking neuronal activity to memory","volume":"39","author":"Sun","year":"2016","journal-title":"Trends Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110302_bib71","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1517\/17460441.2013.815163","article-title":"The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia","volume":"8","author":"Tarazi","year":"2013","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1176\/appi.focus.20230008","article-title":"Treating motivational and consummatory aspects of anhedonia","volume":"21","author":"Treadway","year":"2023","journal-title":"Focus"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110302_bib73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110302_bib74","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13233","article-title":"Assessment of anhedonia in adults with and without mental illness: a systematic review and meta-analysis","volume":"3","author":"Tr\u00f8stheim","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110302_bib75","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/da.21993","article-title":"Self-report and clinician-rated measures of depression severity: can one replace the other?","volume":"29","author":"Uher","year":"2012","journal-title":"Depress. Anxiety"},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110302_bib76","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1523\/JNEUROSCI.20-23-08701.2000","article-title":"Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties","volume":"20","author":"Valjent","year":"2000","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110302_bib77","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1523\/JNEUROSCI.3475-15.2016","article-title":"Catecholamine-mediated increases in gain enhance the precision of cortical representations","volume":"36","author":"Warren","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110302_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","article-title":"Reward processing dysfunction in major depression, bipolar disorder and schizophrenia","volume":"28","author":"Whitton","year":"2015","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110302_bib79","article-title":"Chronic stress weakens connectivity in the prefrontal cortex: architectural and molecular changes","volume":"5","author":"Woo","year":"2021","journal-title":"Chronic stress (Thousand Oaks)"},{"key":"10.1016\/j.neuropharm.2025.110302_bib80","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neubiorev.2021.10.031","article-title":"Age- and sex-specific effects of stress on parvalbumin interneurons in preclinical models: relevance to sex differences in clinical neuropsychiatric and neurodevelopmental disorders","volume":"131","author":"Woodward","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110302_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:28:16Z","timestamp":1774344496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":81,"alternative-id":["S0028390825000085"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110302","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restorative properties of chronic lurasidone treatment on emotional dysfunction in rats exposed to chronic unavoidable stress: A role for medial prefrontal cortex - nucleus accumbens network","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110302"}}